Sivan Bega1, Ayal Schaffer, Benjamin Goldstein, Anthony Levitt. 1. Mood and Anxiety Disorders Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. SivanBega@yahoo.com
Abstract
OBJECTIVE: Bipolar Disorder I (BD I) and Bipolar Disorder II (BD II) vary considerably, with differences in symptomatology, management and prognosis. For patients with depression, the distinction between BD I and BD II is not always apparent, and hinges on the differentiation between manic/mixed and hypomanic episodes. Other putative differences between patients with BD I and II exist and may assist in distinguishing between these two conditions. METHODS: Data were obtained from the National Epidemiological Survey on Alcohol and Related Conditions. A total of 1429 subjects were included in our analysis based on DSM-IV criteria, 935 with BD I and 494 with BD II. We examined for differences in a number of variables including demographics, clinical features, depressive symptoms, and co-morbid conditions using t-tests and chi-square analyses for a comparison of means as well as a logistic regression for variables found to be significant. RESULTS: Key differences between BD I and BD II were identified in all categories in our comparison of means. In the regression analysis, a number of variables were determined to be predictors of BD I, including unemployment (OR=0.6), taking medications for depression (OR=1.7), a history of a suicide attempt (OR=1.8), depressive symptoms such as weight gain (OR=1.7), fidgeting (OR=1.5), feelings of worthlessness (OR=1.6) and difficulties with responsibilities (OR=2.2), as well as the presence of specific phobias (OR=1.8) and Cluster C traits (OR=1.4). CONCLUSIONS: Our results indicate that in addition to the differences between manic/mixed and hypomanic episodes, other significant differences exist that may be used to help differentiate BD I from BD II. Copyright Â
OBJECTIVE:Bipolar Disorder I (BD I) and Bipolar Disorder II (BD II) vary considerably, with differences in symptomatology, management and prognosis. For patients with depression, the distinction between BD I and BD II is not always apparent, and hinges on the differentiation between manic/mixed and hypomanic episodes. Other putative differences between patients with BD I and II exist and may assist in distinguishing between these two conditions. METHODS: Data were obtained from the National Epidemiological Survey on Alcohol and Related Conditions. A total of 1429 subjects were included in our analysis based on DSM-IV criteria, 935 with BD I and 494 with BD II. We examined for differences in a number of variables including demographics, clinical features, depressive symptoms, and co-morbid conditions using t-tests and chi-square analyses for a comparison of means as well as a logistic regression for variables found to be significant. RESULTS: Key differences between BD I and BD II were identified in all categories in our comparison of means. In the regression analysis, a number of variables were determined to be predictors of BD I, including unemployment (OR=0.6), taking medications for depression (OR=1.7), a history of a suicide attempt (OR=1.8), depressive symptoms such as weight gain (OR=1.7), fidgeting (OR=1.5), feelings of worthlessness (OR=1.6) and difficulties with responsibilities (OR=2.2), as well as the presence of specific phobias (OR=1.8) and Cluster C traits (OR=1.4). CONCLUSIONS: Our results indicate that in addition to the differences between manic/mixed and hypomanic episodes, other significant differences exist that may be used to help differentiate BD I from BD II. Copyright Â
Authors: Diana Khoubaeva; Mikaela Dimick; Vanessa H Timmins; Lisa M Fiksenbaum; Rachel H B Mitchell; Ayal Schaffer; Mark Sinyor; Benjamin I Goldstein Journal: Eur Child Adolesc Psychiatry Date: 2021-05-24 Impact factor: 4.785
Authors: Ayal Schaffer; Erkki T Isometsä; Jean-Michel Azorin; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Mark Sinyor; Leonardo Tondo; Doris H Moreno; Gustavo Turecki; Catherine Reis; Lars Vedel Kessing; Kyooseob Ha; Abraham Weizman; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham Journal: Aust N Z J Psychiatry Date: 2015-07-14 Impact factor: 5.744
Authors: A Carlo Altamura; Massimiliano Buoli; Bruno Cesana; Bernardo Dell'Osso; Gianluigi Tacchini; Umberto Albert; Andrea Fagiolini; Andrea de Bartolomeis; Giuseppe Maina; Emilio Sacchetti Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-04-01 Impact factor: 5.270
Authors: Carmen Moreno; Deborah S Hasin; Celso Arango; Maria A Oquendo; Eduard Vieta; Shangmin Liu; Bridget F Grant; Carlos Blanco Journal: Bipolar Disord Date: 2012-12-12 Impact factor: 6.744
Authors: Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Gustavo Turecki; Catherine Reis; Frederick Cassidy; Mark Sinyor; Jean-Michel Azorin; Lars Vedel Kessing; Kyooseob Ha; Tina Goldstein; Abraham Weizman; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Zoltán Rihmer; Lakshmi N Yatham Journal: Bipolar Disord Date: 2014-10-20 Impact factor: 6.744
Authors: U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; E Hoch; K F Mann Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-04-24 Impact factor: 5.270
Authors: U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; K F Mann; E Hoch Journal: Nervenarzt Date: 2016-01 Impact factor: 1.214
Authors: Chi Ming Leung; Chi Lap Yim; Connie T Y Yan; Cheuk Chi Chan; Yu-Tao Xiang; Arthur D P Mak; Marcella Lei-Yee Fok; Gabor S Ungvari Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240
Authors: Jose Guzman-Parra; Fabian Streit; Andreas J Forstner; Jana Strohmaier; Maria José González; Susana Gil Flores; Francisco J Cabaleiro Fabeiro; Francisco Del Río Noriega; Fermin Perez Perez; Jesus Haro González; Guillermo Orozco Diaz; Yolanda de Diego-Otero; Berta Moreno-Kustner; Georg Auburger; Franziska Degenhardt; Stefanie Heilmann-Heimbach; Stefan Herms; Per Hoffmann; Josef Frank; Jerome C Foo; Lea Sirignano; Stephanie H Witt; Sven Cichon; Fabio Rivas; Fermín Mayoral; Markus M Nöthen; Till F M Andlauer; Marcella Rietschel Journal: Transl Psychiatry Date: 2021-01-11 Impact factor: 6.222